This means that more aggressive features of breast cancer, such as higher tumor grade, negative estrogen receptor, HER2 amplification, and inferior overall survival, are evident among female patients with NF1 compared to the age-matched population (7, 106, 107). The gene discussed is NF1; the disease is breast carcinoma.